Trinity Biotech (TRIB) Current Assets (2009 - 2025)

Trinity Biotech's Current Assets history runs 17 years deep, the most recent figure standing at $35.9 million for Q4 2025.

• In Q4 2025, Current Assets fell 12.7% year-over-year to $35.9 million; the TTM figure through Dec 2025 stood at $35.9 million (down 12.7% YoY), while the FY2025 annual figure was $35.9 million, down 12.7% from the prior year.
• Current Assets came in at $35.9 million for Q4 2025 at Trinity Biotech, up from $33.0 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $87.6 million in Q1 2021 to a low of $33.0 million in Q2 2025.
• A 5-year average of $54.1 million and a median of $48.3 million in 2022 frame the typical range for Current Assets.
• Across the five-year window, Current Assets increased 29.85% in 2021 and sank 36.31% in 2022, its largest moves.
• Trinity Biotech's Current Assets stood at $72.7 million in 2021, then slumped by 35.8% to $46.7 million in 2022, then fell by 16.34% to $39.0 million in 2023, then increased by 5.34% to $41.1 million in 2024, then retreated by 12.7% to $35.9 million in 2025.
• According to Business Quant data, Current Assets over the past three periods registered $35.9 million, $33.0 million, and $41.1 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison